These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 17478143

  • 1. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 2. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O, Zahn R, Gitt AK, Bauer T, Juenger C, Senges J, Zeymer U, Maximal Individual Therapy in Acute Myocardial Infarction Plus Study Group.
    Am J Cardiol; 2009 Oct 15; 104(8):1074-7. PubMed ID: 19801027
    [Abstract] [Full Text] [Related]

  • 3. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 15; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 4. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK, Schiele R, Wienbergen H, Zeymer U, Schneider S, Gottwik MG, Senges J, MITRA Study.
    Acta Diabetol; 2003 Dec 15; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [Abstract] [Full Text] [Related]

  • 5. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Jagodzinski E, Senges J, Maximal Individual Therapy in Acute Myocardial Infarction Study Group.
    Am Heart J; 2004 Aug 15; 148(2):306-11. PubMed ID: 15309001
    [Abstract] [Full Text] [Related]

  • 6. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice.
    Zeymer U, Gitt AK, Jünger C, Heer T, Wienbergen H, Koeth O, Bauer T, Mark B, Zahn R, Gottwik M, Senges J, Acute COronary Syndromes (ACOS) registry investigators.
    Eur Heart J; 2006 Nov 15; 27(22):2661-6. PubMed ID: 17043060
    [Abstract] [Full Text] [Related]

  • 7. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A.
    Arch Intern Med; 2010 Aug 09; 170(15):1375-81. PubMed ID: 20696964
    [Abstract] [Full Text] [Related]

  • 8. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 09; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 9. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr 09; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 10. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
    Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Baumgärtel B, Asbeck F, Senges J, Maximum Individual Therapy in Acute Myocardial Infarction (MITRA), Myocardial Infarction Registry (MIR) Study Groups.
    Am Heart J; 2001 Feb 09; 141(2):200-5. PubMed ID: 11174332
    [Abstract] [Full Text] [Related]

  • 11. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P, Cambou JP, Guéret P, Vaur L, Boutalbi Y, Genès N, Lablanche JM, USIC 2000 Investigators.
    Circulation; 2004 Oct 05; 110(14):1909-15. PubMed ID: 15451803
    [Abstract] [Full Text] [Related]

  • 12. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV, Ohman EM, Gibler WB, Peterson ED.
    Am J Med; 2007 Aug 05; 120(8):685-92. PubMed ID: 17679127
    [Abstract] [Full Text] [Related]

  • 13. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U, Gitt A, Jünger C, Bauer T, Heer T, Koeth O, Mark B, Zahn R, Senges J, Gottwik M.
    Thromb Haemost; 2008 Jan 05; 99(1):155-60. PubMed ID: 18217148
    [Abstract] [Full Text] [Related]

  • 14. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A, Siudak Z, Dykla D, Rakowski T, Mielecki W, Dubiel JS, Dudek D.
    Kardiol Pol; 2009 Feb 05; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [Abstract] [Full Text] [Related]

  • 15. Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR).
    Gottwik M, Zahn R, Schiele R, Schneider S, Gitt AK, Fraunberger L, Bossaller C, Glunz HG, Altmann E, Rosahl W, Senges J, Myocardial Infarction Registry (MIR)-Study Groups.
    Eur Heart J; 2001 Oct 05; 22(19):1794-801. PubMed ID: 11549301
    [Abstract] [Full Text] [Related]

  • 16. [Impact of reperfusion strategies on in-hospital outcome in ST-elevation myocardial infarction in a context of interhospital network: data from the prospective VENERE registry (VENEto acute myocardial infarction REgistry].
    Di Pede F, Olivari Z, Schievano E, Spolaore P, Cacciavillani L, La Vecchia L, Bruni A, Zuin G, Franco GF, Palatini O, Morando G, Tinto M, Rossi M, Guarnerio M, Ricercatori del Registro VENERE.
    Ital Heart J Suppl; 2005 Dec 05; 6(12):804-11. PubMed ID: 16444924
    [Abstract] [Full Text] [Related]

  • 17. Age differences in the adherence to treatment guidelines and outcome in patients with ST-elevation myocardial infarction.
    Gottlieb S, Behar S, Schwartz R, Harpaz D, Shotan A, Zahger D, Hod H, Tzivoni D, Moriel M, Israeli Working Group on Intensive Cardiac Care, Israel Heart Society.
    Arch Gerontol Geriatr; 2011 Dec 05; 52(1):118-24. PubMed ID: 20399515
    [Abstract] [Full Text] [Related]

  • 18. Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR).
    Zahn R, Schiele R, Schneider S, Gitt AK, Wienbergen H, Seidl K, Bossaller C, Hauf GF, Gottwik M, Altmann E, Rosahl W, Senges J.
    J Invasive Cardiol; 2001 May 05; 13(5):367-72. PubMed ID: 11385150
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 20. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events.
    Emery M, López-Sendón J, Steg PG, Anderson FA, Dabbous OH, Scheuble A, Eagle KA, GRACE Investigators.
    Am Heart J; 2006 Dec 15; 152(6):1015-21. PubMed ID: 17161045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.